Physician profile
Nagarajan Devar
NPI 1366491995
$1,357.11
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $525 · 2021: $285.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $192.64 | 2019-2020 | |
| Amgen INC. | $161.02 | 2019-2021 | |
| Lilly USA, LLC | $131.95 | 2019 | |
| Pfizer INC. | $98.41 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $82.56 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $76.98 | 2019-2021 | |
| Astellas Pharma US INC | $72.09 | 2019-2020 | |
| Novo Nordisk INC | $69.10 | 2020-2021 | |
| Amarin Pharma, INC. | $69.10 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $57.04 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.54 | 2020-2021 | |
| Grt US Holding, INC. | $49.09 | 2021 | |
| Ibsa Pharma INC. | $46.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $40.76 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $38.13 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $28.05 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.04 | 2020 | |
| Allergan, INC. | $21.34 | 2020 | |
| Sunovion Pharmaceuticals INC. | $19.63 | 2021 | |
| Eisai INC. | $14.97 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.67 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nagarajan Devar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.